medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2022, Number 2

<< Back Next >>

Rev ADM 2022; 79 (2)

Porphyromonas gingivalis in gingival fluid from type 2 diabetic patients, and its relationship with glycemic control.

Britos MR, Sin S, Ortega SM

Language: Spanish
References: 41
Page: 85-91
PDF size: 238.05 Kb.


ABSTRACT

Introduction: The objective of this research was to establish the prevalence of Porphyromonas gingivalis in patients suffering from type 2 diabetes mellitus and to evaluate its relationship with the stages of periodontitis and the metabolic condition of glucose. Material and methods: 50 patients of both sexes who met the inclusion criteria participated. The degree of periodontal disease was defined according to Papapanou et al. gingival fluid samples were taken at two deeper sites. Porphyromonas gingivalis was detected by polymerase chain reaction (PCR). Metabolic compensation was assessed by measuring glycosylated hemoglobin. Results: The distribution of the degrees of periodontitis as a function of the metabolic control of glycemia did not present statistical significance (p = 0.8633). According to the methodology used, the prevalence of Porphyromonas gingivalis in gingival fluid was 30%. No statistically significant differences were found between the presence of Porphyromonas gingivalis and metabolic glycemic control (p = 0.6997). The presence of Porphyromonas gingivalis as a function of the degree of Periodontitis did not present statistically significant differences (p = 0.5188). Conclusion: The prevalence of Porphyromonas gingivalis does not influence type 2 Diabetes Mellitus, likewise the metabolic control of glucose and the presence of periodontal disease behave independently.


REFERENCES

  1. Kilian M, Chapple ILC, Hannig M, Marsh PD, Meuric V, Pedersen AML. The oral microbiome–an update for oral healthcare professionals. British Dental J. 2016; 221 (10): 657-666. Available in: https://www.nature.com/articles/sj.bdj.2016.865.pdf

  2. Devine DA, Marsh PD, Meade J. Modulation of host responses by oral comensal bacteria. J Oral Microbiol. 2015; 7: 26941. Available in: https://www.tandfonline.com/doi/pdf/10.3402/jom.v7.26941

  3. Takahashi N. Oral microbiome metabolism: from "who are they?" to "what are they doing?" J Dent Res. 2015; 94 (12): 1628-1637.

  4. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol. 1992; 63 (4 Suppl): 322-331.

  5. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontology 2000. 2005; 38: 135-187.

  6. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999; 4: 1-6. Available in: http://www.joponline.org/doi/pdf/10.../annals.1999.4.1.1

  7. Calsina GG, Simó SO. Diabetes y enfermedad periodontal. FMC. 2017; 24 (2): 64-9. Disponible en: http://residen-ciamflapaz.com/Articulos%20Residencia%2017/87%20Diabetes%20y%20enfermedad%20periodontal.pdf

  8. Arana MC, Florencio OL, Sevillano JM, Morales PC, Serrano OI, Hernández TM et al. Diabetes and periodontal diseases: an established two-way relationship. J Diabetes Mellitus. 2016; 6 (04): 209-229. Available in: http://file.scirp.org/pdf/ JDM_2016091313385917.pdf

  9. Moreno FJM. Asociación entre la diabetes mellitus descontrolada y la progresión de la periodontitis: Revisión bibliográfica. Depósito de investigación Universidad de Sevilla. 2017. Disponible en: https://idus.us.es/handle/11441/65095

  10. Punthakee Z, Goldenberg R, Katz P. Diabetes Canada Clinical Practice Guidelines Expert Committee. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2018; 42: S10-S15. Available in: https://pubmed.ncbi.nlm.nih.gov/29650080/

  11. Guías ALAD sobre el diagnóstico, control y tratamiento de la diabetes mellitus tipo 2 con medicina basada en evidencia. Rev ALAD. 2019. Disponible en: https://revistaalad.com/guias/5600AX191_guias_alad_2019.pdf

  12. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Byrd-Holt D. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998; 21 (4): 518-524. Available in: https://www.researchgate.net/profile/Katherine_Flegal/publication/13709843_Prevalence_of_Diabetes_Impaired_Fasting_Glucose_and_Impaired_Glucose_Tolerance_in_US_A

  13. Loe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993; 16 (1): 329-334. Available in: https://www.academia.edu/2215442/Periodontal_disease_the_sixth_complication_of_diabetes_mellitus?auto=citations&from=cover_page

  14. De'Marziani G, Elbert AE. Hemoglobina glicada (HbAa1c). Utilidad y limitaciones en pacientes con enfermedad renal crónica. Rev Nefrol Diál Traspl. 2018; 38 (1): 65-83. Disponible en: https://www.revistarenal.org.ar/index.php/rndt/article/view/300

  15. Britos MR, Sin CS, Ortega SM. Enfermedad periodontal y su implicancia en la diabetes mellitus: revisión de la literatura. Rev Ateneo Argent Odontol. 2019; 60 (1): 33-40. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1119529

  16. Torres-López M, Díaz-Álvarez M. La diabetes mellitus y su vinculación en la etiología y patogenia de la enfermedad periodontal. Gac Méd Espirit. 2007; (2): 14. Disponible en: http://revgmespirituana.sld.cu/index.php/gme/article/view/794

  17. Jaramillo Echeverri A. Asociación entre síndrome metabólico y enfermedad periodontal en personas que asisten a 5 instituciones de salud en Cali, Medellín y Bogotá. [Internet]. Montevideo, Uruguay: Universidad de la República 2017; [recurso electrónico] (Doctoral dissertation). Disponible en: http://bibliotecadigital.univalle.edu.co/bitstream/1089

  18. How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016; 7: 53. Available in: https://pubmed.ncbi.nlm.nih.gov/26903954/ doi.org/10.3389/fmicb.2016.00053

  19. Mulhall H, Huck O, Amar S. Porphyromonas gingivalis, a long-range pathogen: systemic impact and therapeutic implications. Microorganisms. 2020; 8 (6): 869. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357039/

  20. Moreno del Castillo MC, Valladares-García J, Halabe-Cherem J. Microbioma humano. Rev Facultad de Medicina UNAM. 2018; 61 (6): 7-19. Disponible en: https://www.medigraphic.com/pdfs/facmed/un-2018/un186b.pdf

  21. Rocha Leon VH, Nobre dos Santos Lima E, Montino Pimentel AC, Mares de Miranda P, Carvalho Filho C, Castro Trindade S, Tosta Xavier M. Porphyromona gingivalis and chronic periodontitis recent advances. Rev Bahiana Odontol. 2016; 7 (2): 147-154. Available in: https://www5.bahiana.edu.br/index.php/odontologia/article/view/885/633 doi: 10.17267/2238-2720revbahianaodonto.v7i2.885.

  22. Seyama M, Yoshida K, Yoshida K, Fujiwara N, Ono K, Eguchi T, Uchibe K. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver. Biochim Biophys Acta Mol Basis Dis. 2020; 1866 (6): 165731 D Available in: https://pubmed.ncbi.nlm.nih.gov/32088316/

  23. Tian J, Liu C, Zheng X, Jia X, Peng X Yang R, Zhou X, Xu X. Porphyromonas gingivalis induces insulin resistance by increasing BCAA levels in mice. J Dent Res. 2020; 99 (7): 839-846. Available in: https://pubmed.ncbi.nlm.nih.gov/32176550/ doi: 10.1177/0022034520911037

  24. Yang R, Dong J, Zhao H, Li H, Guo H, Wang S et al. Association of branched-chain amino acids with carotid intima-media thickness and coronary artery disease risk factors. PLoS One. 2014; 9 (6): e99598. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049830/

  25. Ruiz-Canela M, Toledo E, Clish CB, Hruby A, Liang L, Salas-Salvadó J et al. Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED Trial. Clin Chem. 2016; 62: 582-592. Available in: https://pubmed.ncbi.nlm.nih.gov/26888892/

  26. Yang RY, Wang SM, Sun L, Liu JM, Li HX, Sui XF et al. Association of branched-chain amino acids with coronary artery disease: a matched-pair case-control study. Nutr Metab Cardiovasc Dis. 2015; 25: 937-942. Available in: https://pubmed.ncbi.nlm.nih.gov/26231617/

  27. Takamura H, Yoshida K, Okamura H, Fujiwara N, Ozaki K. Porphyromonas gingivalis attenuates the insulin-induced phosphorylation and translocation of forkhead box protein O1 in human hepatocytes. Arch Oral Biol. 2016; 69: 19-24. Available in: https://pubmed.ncbi.nlm.nih.gov/27214121/

  28. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH et al. Periodontitis: Consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol. 2018; 45 (Suppl 20): 162-170. Available in: https://aap.onlinelibrary.wiley.com/doi/pdf/10.1002/JPER.17-0721

  29. Quintero AJ, Prada P, Inostroza CM, Chaparro A, Sanz AF, Ramírez VL, Morales HC. Presencia de Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola y Aggregatibacter actinomycetemcomitans en el biofilm subgingival de pacientes diabéticos tipo 2: estudio transversal. Rev Clin Periodoncia Implantol Rehabil Oral. 2011; 4: 54-58. Disponible en: www.scielo.cl/pdf/piro/v4n2/art03.pdf

  30. Rojo BNR, Flores EA, Arcos CM. Prevalencia, severidad y extensión de periodontitis crónica. Rev Odont Mex. 2011; 15 (1): 31-39. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870-199X2011000100006&lng=es

  31. Rohlfs I, Borrell C, Fonseca M. Género, desigualdades y salud pública: conocimientos y desconocimientos. Gac Sanit. 2000; 14 (Supl. 3): 60-71. https://www.gacetasanitaria.org/es-vol-14-num-s3-sumario-X0213911100X80547

  32. Sandín M, Espeltb A, Escolar-Pujol A, Arriola l, Larrañaga I. Desigualdades de género y diabetes mellitus tipo 2: La importancia de la diferencia. Av Diabetol. 2011; 27 (3): 78-87. Disponible en: https://www.elsevier.es/es-revista-avances-diabetologia-326-sumario-vol-27-num-3

  33. Agarwal R, Baid R. Periodontitis and diabetes: a bidirectional, cyclical relationship - A brief review. Acta Med Int. 2017; 4: 46-49. Available in: https://www.actamedicainternational.com/text.asp?2017/4/2/46/217262

  34. Cordovez CAG. Prevalencia de periodontitis y su grado de severidad en pacientes del grupo de diabéticos del Hospital Vozandes Quito. COBUEC 2018. Disponible en: https://www.bibliotecasdelecuador.com/Record/ir-:33000-8440

  35. Simpson TC, Weldon JC, Worthington HV et al. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev. 2015; 11: CD004714.21. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486035/

  36. Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treat-ment on glycemic control of diabetic patients: a systematic re-view and meta-analysis. Diabetes Care. 2010; 33: 421-427. Available in: doi: 10.2337/dc09-1378.

  37. Demmer RT, Squillaro A, Papapanou PN et al. Periodontal infection, systemic inflammation, and insulin resistance: results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care 2012; 35: 2235-2242. Available in: https://pubmed.ncbi.nlm.nih.gov/22837370/

  38. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-1801. Available in: https://doi.org/10.1172/JCI29069

  39. Choi YH, McKeown RE, Mayer-Davis EJ, Liese AD, Song KB, Merchant AT. Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia. J Periodontol. 2014; 85 (9): 1172-1181. Available in: https://pubmed.ncbi.nlm.nih.gov/24410292/

  40. Makiura N, Ojima M, Kou Y, Furuta N, Okahashi N, Shizukuishi S et al. Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2diabetes following periodontal treatment. Oral Microbiol Immunol. 2008; 23: 348-351. Available in: https://pubmed.ncbi.nlm.nih.gov/18582336/

  41. Ramos PD, Churata ODE, Paccori GE, Malpartida PK, Cuentas RA, Arbañil HH et al. Presencia de bacilos negro pigmentantes en bolsas periodontales de pacientes diabéticos tipo 2 y su relación con el control glicémico. Revista Estomatológica Herediana 2017; 27(1): 30-38. Disponible en: http://www.scielo.org.pe/pdf/reh/v27n1/a05v27n1.pdf




2020     |     www.medigraphic.com